Monoclonal Antibodies for Treatment of COVID-19
Who is eligible for monoclonal antibody treatment?
Any patient 12 years of age or older who has tested positive for COVID-19. Patients experiencing mild/moderate symptoms - without increased oxygen requirements from symptom onset. Patients who a medical provider deems "high-risk" for their symptoms progressing to a severe level.
If you are a Cancer or Transplant patient, please click here for more details
Patients must be within seven days of when their symptoms started.
Frequently Asked Questions
What does the treatment do?
Helps reduce hospitalizations and prevent worsening of COVID-19 symptoms. Monoclonal antibodies are like the antibodies that are naturally made by the immune system in response to an infection, except a monoclonal antibody is made in a lab so that it only binds to one substance. You may not feel better right away after receiving Monoclonal antibody treatment, but that does not mean it isn’t working. The main goal of the treatment is to prevent worsening symptoms that would require admission to the hospital.
How does it work?
Monoclonal antibodies have been granted Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) for COVID-19 treatment. They are man-made proteins that act like a human antibody in the immune system, defending the body’s cells against the COVID-19 virus. This treatment has been shown to prevent the virus from worsening and spreading.
How is the treatment administered?
The monoclonal antibodies are delivered through a single hour-long infusion treatment. After the procedure, patients are monitored for another hour to ensure there are no side effects and then return home to continue their recovery.
How much does it cost?
The monoclonal antibodies are provided free of charge, however, TGH will bill your health insurance (if applicable) for the medication administration and supply costs.
How long does the treatment take?
The visit will take about 3 to 3½ hours. You may want to bring a drink, a snack, and sweater as it may be chilly. One (1) hour for the Screen on arrival, One (1) hour for the infusion itself and One (1) for observation. Please arrive 15 minutes before your scheduled appointment.
For more information, contact:
TGH Global Emerging Diseases Institute
GEDIclinic@tgh.org | (813) 844-4715
Visit TGH.org/GEDIReferral and complete the GEDI Infusion Center referral form.